Gemzar gemcitabine: Phase III data

In a U.K. Phase III trial in 410 patients, Gemzar plus cisplatin significantly increased median OS vs. Gemzar alone (11.7 vs. 8.1 months, p<0.001). The combination also significantly increased median ...